Szilárd Tóth

806 total citations
39 papers, 612 citations indexed

About

Szilárd Tóth is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Szilárd Tóth has authored 39 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in Szilárd Tóth's work include Drug Transport and Resistance Mechanisms (12 papers), Metal complexes synthesis and properties (10 papers) and Cancer therapeutics and mechanisms (6 papers). Szilárd Tóth is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Metal complexes synthesis and properties (10 papers) and Cancer therapeutics and mechanisms (6 papers). Szilárd Tóth collaborates with scholars based in Hungary, Austria and United States. Szilárd Tóth's co-authors include Gergely Szakács, Veronika F.S. Pape, András Füredi, Kornélia Szebényi, Pál Szabó, József Tóvári, Gábor Mező, Anna Lovrics, Michael Wiese and Dávid Szüts and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Szilárd Tóth

34 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Szilárd Tóth Hungary 14 308 248 211 46 43 39 612
Jo Ann W. Byl United States 16 268 0.9× 607 2.4× 242 1.1× 28 0.6× 17 0.4× 24 807
Zhongren Xu China 10 171 0.6× 171 0.7× 152 0.7× 35 0.8× 32 0.7× 17 494
Xinhui Zhang China 16 224 0.7× 398 1.6× 271 1.3× 30 0.7× 15 0.3× 32 776
Akinobu Kurita Japan 13 191 0.6× 305 1.2× 101 0.5× 26 0.6× 86 2.0× 26 539
Dipayan Bose India 14 197 0.6× 206 0.8× 123 0.6× 41 0.9× 9 0.2× 31 567
Kahlin Cheung-Ong Canada 6 251 0.8× 514 2.1× 85 0.4× 92 2.0× 31 0.7× 6 762
Virginia Appleyard United Kingdom 8 236 0.8× 302 1.2× 73 0.3× 40 0.9× 17 0.4× 10 752
Antonella Pepe United States 13 108 0.4× 264 1.1× 228 1.1× 28 0.6× 18 0.4× 25 550
Wendy Dangerfield New Zealand 7 419 1.4× 366 1.5× 292 1.4× 24 0.5× 42 1.0× 7 805
Mirosława Koronkiewicz Poland 15 129 0.4× 277 1.1× 180 0.9× 102 2.2× 14 0.3× 46 635

Countries citing papers authored by Szilárd Tóth

Since Specialization
Citations

This map shows the geographic impact of Szilárd Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szilárd Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szilárd Tóth more than expected).

Fields of papers citing papers by Szilárd Tóth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szilárd Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szilárd Tóth. The network helps show where Szilárd Tóth may publish in the future.

Co-authorship network of co-authors of Szilárd Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Szilárd Tóth. A scholar is included among the top collaborators of Szilárd Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szilárd Tóth. Szilárd Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dömötör, Orsolya, Éva Bakos, Csilla Özvegy‐Laczka, et al.. (2025). Comparative study of multidrug resistance-targeting 8-hydroxyquinoline-amino acid conjugates: anticancer effect, interaction with human serum albumin and organic anion transporting polypeptides. European Journal of Pharmaceutical Sciences. 212. 107187–107187.
2.
3.
Tóth, Szilárd, Nóra V. May, Éva Kováts, et al.. (2024). Organometallic Half-Sandwich Complexes of 8-Hydroxyquinoline-Derived Mannich Bases with Enhanced Solubility: Targeting Multidrug Resistant Cancer. Inorganic Chemistry. 63(50). 23983–23998. 3 indexed citations
4.
Petri, László, Péter Ábrányi‐Balogh, Szilárd Tóth, et al.. (2023). Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency. European Journal of Medicinal Chemistry. 250. 115212–115212. 3 indexed citations
5.
6.
Bagi, Péter, Szilárd Tóth, Gergely Szakács, et al.. (2022). Efficient Synthesis of Acylated, Dialkyl α-Hydroxy-Benzylphosphonates and Their Anticancer Activity. Molecules. 27(7). 2067–2067. 4 indexed citations
7.
Tóth, Szilárd, et al.. (2022). Optimized Synthesis and Cytotoxic Activity of α-AminophosphonatesAgainst a Multidrug Resistant Uterine Sarcoma Cell Line. Letters in Drug Design & Discovery. 20(3). 365–371. 8 indexed citations
8.
Nagy, Sándor, et al.. (2022). Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA/Dx5 multidrug-resistant uterine sarcoma cell lines. Bioorganic & Medicinal Chemistry. 67. 116855–116855. 8 indexed citations
9.
Tóth, Szilárd, Viet‐Khoa Tran‐Nguyen, Balázs Sarkadi, et al.. (2020). Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance. Molecules. 25(3). 764–764. 20 indexed citations
10.
Cserepes, Mihály, Dóra Türk, Szilárd Tóth, et al.. (2019). Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein–Expressing Cells. Cancer Research. 80(4). 663–674. 29 indexed citations
11.
Rádai, Zita, Véronika Nagy, András Füredi, et al.. (2019). Synthesis and anticancer cytotoxicity with structural context of an α-hydroxyphosphonate based compound library derived from substituted benzaldehydes. New Journal of Chemistry. 43(35). 14028–14035. 16 indexed citations
12.
Tóth, Szilárd, et al.. (2019). Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen. Archives of Toxicology. 93(4). 953–964. 25 indexed citations
13.
Póti, Ádám, Eszter Németh, Orsolya Rusz, et al.. (2019). Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents. Genome biology. 20(1). 240–240. 72 indexed citations
14.
Tóth, Szilárd, István Szabadkai, Ferenc Baska, et al.. (2018). Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters. PLoS ONE. 13(9). e0202749–e0202749. 6 indexed citations
15.
Tóth, Szilárd, et al.. (2017). NGR-peptide−drug conjugates with dual targeting properties. PLoS ONE. 12(6). e0178632–e0178632. 41 indexed citations
16.
Füredi, András, Szilárd Tóth, Kornélia Szebényi, et al.. (2016). Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity. Molecular Cancer Therapeutics. 16(1). 45–56. 41 indexed citations
17.
Pape, Veronika F.S., Szilárd Tóth, András Füredi, et al.. (2016). Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. European Journal of Medicinal Chemistry. 117. 335–354. 97 indexed citations
18.
Pepó, Péter, et al.. (2009). Morphological and biochemical indicators of drought tolerance in sweet sorghum (Sorghum dochna L.).. Cereal Research Communications. 37. 157–160. 1 indexed citations
19.
Tóth, Szilárd & Zoltán Bódi. (2006). Gene Bank Developed by Induced Mutation for Selection. Acta Agraria Debreceniensis. 45–49.
20.
Bódi, Zoltán, et al.. (2006). Investigation of genetic diversity in irradiated maize lines and its relation to hybrid performance. Acta Agraria Debreceniensis. 20–26. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jo Ann W. Byl Breakdown of academic impact, for papers by Zhongren Xu Breakdown of academic impact, for papers by Xinhui Zhang Breakdown of academic impact, for papers by Akinobu Kurita Breakdown of academic impact, for papers by Dipayan Bose Breakdown of academic impact, for papers by Kahlin Cheung-Ong Breakdown of academic impact, for papers by Virginia Appleyard Breakdown of academic impact, for papers by Antonella Pepe Breakdown of academic impact, for papers by Wendy Dangerfield Breakdown of academic impact, for papers by Mirosława Koronkiewicz
Rankless by CCL
2026